RLS drug study seeks gene clues behind worsening symptoms
NCT ID NCT06726785
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 29 times
Summary
This study looks at how taking certain RLS medications for a long time may change the activity of genes in nasal cells. Researchers will compare people who have used these drugs for less than a month to those who have used them for six months or more. The goal is to understand why some patients develop worsening symptoms, called augmentation syndrome. The study involves 50 adults with RLS who are currently on a dopamine agonist like pramipexole or ropinirole.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESTLESS LEG SYNDROME (RLS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alethios Inc
RECRUITINGSan Francisco, California, 94109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.